Skip to main content
. Author manuscript; available in PMC: 2017 Feb 8.
Published in final edited form as: J Mol Cell Cardiol. 2009 Sep 18;48(2):310–321. doi: 10.1016/j.yjmcc.2009.09.004

Table 1.

Comparison of metabolic flux and physiological parameters assessed in 12-week-old C57BL/10 and mdx mouse hearts perfused with 13C-labeled substrates.

Measured parameters mdx vs. C57BL/10 (ratio)
(1) Metabolic flux parameters assessed at 30 min
(A) Cytosolic ↑(1.62)*
 Glycolysis (production of lactate and pyruvate)
(B) Mitochondria
(i) Relative contribution of substrates to citrate synthesis
 –Carbohydrate oxidation: pyruvate decarboxylation (PDC/CS) ↑ (2.20)**
 –Fatty acid oxidation: oleate β-oxydation (OLE/CS) ↓ (0.73)*
 –Oxidation of other substrates (OS/CS) NS
 –Anaplerosis: pyruvate carboxylation (PC/CS) ↓ (0.81)*
(ii) Citric acid cycle-related parameters
 –Citric acid cycle intermediate levels ↓ (0.66)**
 –Aconitase activity ↓ (0.72)*
 –Citrate synthase activity NS
 –Calculated ATP production rates ↑ (1.17)*
(2) Physiological parameters assessed at 2530 min
 –Aortic flow ↑ (0.83)*
 –Coronary flow NS
 –Left ventricular systolic pressure ↓ (0.90)*
 –Left ventricular end diastolic pressure NS
 –Heart rate NS
 –dP/dtmax ↓ (0.84)**
 –dP/dtmin ↓ (0.87)*
 –Oxygen consumption ↑ (1.18)**
 –Lactate dehydrogenase release ↑ (2.60)**

Metabolic and functional data are from [8]. The following metabolic parameters were assessed in working hearts perfused for 30 min with physiological concentrations of carbohydrates (11 mM glucose, 1.5 mM lactate and 0.2 mM pyruvate) and a fatty acid (0.4 mM oleate bound to albumin) using 13C-labeled substrates and mass isotopomer analysis by gas chromatography-mass spectrometry: (A) Glycolysis reflecting the production of lactate and pyruvate from 13C-glucose (μmol×min−1). (B.i) Substrate flux ratios reflecting the contribution of exogenous fatty acids (oleate) and carbohydrates (CHOs: lactate, pyruvate and glucose) to citrate formation via (i) acetyl-CoA (energy) from oleate β-oxidation (OLE) and pyruvate decarboxylation (PDC), or (ii) oxaloacetate (anaplerosis) from pyruvate carboxylation (PC), all expressed relative to citrate synthesis (CS); (B.ii) Tissue concentration of citric acid cycle (CAC) intermediates (in μmol×g wet weight−1), tissue aconitase and citrate synthase activity (μmol×min−1×mg protein−1) and calculated ATP production rates.

*

p<0.05,

#

p< 0.001 for mdx versus control mouse hearts; NS: not significant.

HHS Vulnerability Disclosure